Therapeutic protein degradation by design
Hot targets in drug discovery are constantly changing, paradigm shifts are a bit rarer. Protein degradation is an exciting new example of the latter. Martin Slater describes how Cresset Discovery Services tackles therapeutic protein degradation by design.
Presentations from Cresset User Group Meeting 2019
Thank you to all attendees who contributed to the success of the Cresset User Group Meeting 2019. See the presentations we have permission to publish. We hope to see you at the Cresset User Group Meeting 2020 on 18-19 June in Cambridge, UK.
Review of Efficient Drug Discovery Through Connected Chemistry symposium
Merck Research Laboratories, Boston, was the host for this meeting with a central theme 'Design, Make, Test and Analysis', effecting efficient collaboration, and information sharing across all processes involved with drug discovery, design and synthesis (Design-Make-Test- Analysis, DMTA). Rachelle Bienstock reviews the presentations.
Presentation and posters from 8th Joint Sheffield Conference on Chemoinformatics
- Design in 2D, model in 3D: Live 3D pose generation from 2D sketches
- PickR: Pick diverse R-groups for library design using 3D electrostatics and shape
- Developing a robust method for automated assessment of binding affinity via FEP
New Cresset website design launched
The intuitive navigation of the new Cresset website presents our software and services offering in a clear structure, helping computational chemists, medicinal chemists, biologists and academics find the right solutions to progress their project.